Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, Inc. (MPLT), sold 118,235 shares at $27.19 ($3.2M) on 2026-05-18, disclosed to the SEC on 2026-05-18.
Scheduled sale ($3.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.19 | 118,037 | $3.2M | 99.8% |
| 2 | $28.15 | 198 | $6K | 0.2% |
| Total | $27.19 avg | 118,235 | $3.2M | 100% |
| Filing → |
| MPLT | SELL | 2026-05-06 | $1.4M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $521K | — | Filing → |